biotechandmoney.com Report : Visit Site

Technical data of the biotechandmoney.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host biotechandmoney.com. Currently, hosted in United Kingdom and its service provider is Webfusion Internet Solutions .

the related websites

swabtech.co.uk britisheventing.com telegraph.co.uk 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called cloudflare containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

need any help ? investor portal about about offering partners testimonials contact membership benefits premium members join partners events upcoming events past events investor portal resources all resources blog deals watch executive and expert insights executive publications and reports investorviews featured videos contact us the exclusive community for senior life science executives the exclusive community for senior life science executives join the fastest growing life science community for corporates, investors and pharma what is biotech and money biotech and money is an influential community of senior life science decision makers. through our impactful events, powerful thought leadership content and unique networking opportunities, we exist to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare. our conference and community brands next event 29-30 august 2018, nasdaq stockholm, sweden the event takes place from 8.00 am - 11.00 am on 24th may 2016 at k&l gates london office -- events flagship events ceo forums evening socials showcases past events lsx nordic congress on 29-30th august 2018 at nasdaq offices, stockholm the lsx nordic congress is a high-calibre, senior executive conference and partnering event providing the education, strategies, solutions, and contacts that life science companies need to enable more effective investment, business planning and partnering within their businesses. the nordic region has long produced world-leading science and innovation and nasdaq nordic is one of the leading hubs for biotech companies in europe, strengthened further by a hugely active ipo market over the last two years. lsx connect: summer 27th june 2018 at cms offices, cannon street, london lsx connect: summer is a networking event for senior life science executives organised by lsx ltd., formerly biotech and money. the 3hr evening function serves as an informal forum for up to 70 executives to come together, network and enjoy a relaxed evening with their peers and protégés, together with timely and pertinent presentations or panels. lsx world congress usa on 10-11th october 2018 at one boston place, convene, boston, ma the lsx world congress usa is a high-calibre, senior executive, two-day conference and partnering event providing the education, strategies, solutions and contacts that life science companies need to enable more effective funding, investment, planning and growth within their businesses. the us version of the world congress follows on from five previous highly successful congresses following the unique style and format of lsx, formerly biotech and money. lsx european ceo forum september 2018 at cms offices, 78 cannon street, london lsx european ceo forum is a 40-person chatham house rule, formatted forum in which ceos and cfos from innovative life science companies discuss and shape the future of their sector behind closed doors. they are hollow-square formats and not your standard one-dimensional meeting format meaning all executives engage in meaningful strategic and sector debate and discussion. the forums will address the key industry challenges head-on, providing genuine outcomes for the executives and the sector as a whole. biotech and money world congress 2019 on 5-6th february 2019 at etc. venues, 200 aldersgate, st pauls, london biotech and money / medtech and money world congress is a two-day flagship uk annual congress for c-level biopharma executives. the event provides crowd-sourced insight, strategies, and tactics to enable more effective funding, investment and partnering within your business. it features a series of keynote sessions, group discussions, interactive roundtables, fireside panels, inv€$table showcases and bootcamps, all ran alongside structured 1-2-1 partnering. inv£$table showcases on 5th & 6th february 2017 at etc. venues, 155 bishopsgate we've created space for 55+ presentation showcases for biotech and medtech companies over the course of the 2-day event. this provides a unique opportunity for outlining your company's vision, track record and future plans. world healthex forum on 13th november 2017 at etc. venues, 200 aldersgate, london the healthex world forum is a dynamic, outcome oriented summit for c-suite and board level executives from the worlds of pharma, health technology, finance, and government, dedicated to finding solutions to the health industry’s most pressing challenges through debate, dialogue and collaboration. in£$tival showcase on 14th november 2017 at hilton waldorf hotel inv€$tival showcase november 2018 venue tbc in exclusive partnership with jefferies llc, the inv€$tival showcase spans 4-tracks and will feature the most exciting companies across 7 key sub-sectors within life sciences. the global list of presenting companies will span corporates invovled in the world healthex forum on november 13, as well as the most exciting and innnovative new companies looking to raise capital or profile with investors, brought together through both biotech and money and jefferies' investor networks. /*fliter script*/ executive interviews and insights -- executive and expert insights investorview: plugging knowledge gaps to accelerate life science start-up development venture capital firm hadean ventures closed its first fund at the end of 20... read more xplico: supporting strategic decision-making through life science valuations key learnings: headquartered in copenhagen, xplico has been providing valua... read more novoheart expands global presence to support commercial potential of bioengineered human hearts key learnings: novoheart has developed human bioengineered heart constructs... read more executive publications and reports have your say in the lsx c-suite challenges in life sciences survey 2018 what are the biggest obstacles to securing financing? what challenges do yo... read more how to manage whistleblowing in life sciences whistleblowing, along with the impact that it can have on organisations, ha... read more infographic: preparing for gdpr two years after gaining approval from the european parliament, the general ... read more featured videos interview with hemogenyx's vladislav sandler in this video, donald leggatt, head of investor re... read more interview with inmedix’s andrew j. holman andrew j. holman, co-founder and chief executive o... read more interview with repositive’s fiona nielsen fiona nielsen, founder and chief executive officer... read more community partners join us about us biotech and money is the influential community of senior life science decision makers site map resources membership contact us partners blog events privacy policy help contact us join for free twitter feed tweets by @biotechandmoney © 2018 all rights reserved by biotech and money / lsx limited

URL analysis for biotechandmoney.com

https://www.biotechandmoney.com/deals-watch
https://www.biotechandmoney.com/blog/investorview-plugging-knowledge-gaps-to-accelerate-life-science-start-up-development?hslang=en-gb
https://www.biotechandmoney.com/executive-and-expert-insights
https://www.biotechandmoney.com/company-testimonial
https://www.biotechandmoney.com/investor-portal-access
https://www.biotechandmoney.com/offering
https://www.biotechandmoney.com/events
https://www.biotechandmoney.com/blog/novoheart-expands-global-presence-to-support-commercial-potential-of-bioengineered-human-hearts?hslang=en-gb
https://www.biotechandmoney.com/benefits
https://www.biotechandmoney.com/blog/interview-with-hemogenyxs-vladislav-sandler?hslang=en-gb
https://www.biotechandmoney.com/join-for-free
https://www.biotechandmoney.com/partners
/www.biotechandmoney.com/privacy-policy
https://www.biotechandmoney.com/investor-portal?hslang=en-gb
https://www.biotechandmoney.com/executive-publications-and-reports
surveymonkey.co.uk

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: BIOTECHANDMONEY.COM
Registry Domain ID: 1845728235_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.123-reg.co.uk
Registrar URL: http://www.meshdigital.com
Updated Date: 2018-01-31T15:16:21Z
Creation Date: 2014-02-07T12:37:39Z
Registry Expiry Date: 2019-02-07T12:37:39Z
Registrar: 123-Reg Limited
Registrar IANA ID: 1515
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS.123-REG.CO.UK
Name Server: NS2.123-REG.CO.UK
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-03-22T17:17:07Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR 123-Reg Limited

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =biotechandmoney.com

  PORT 43

  TYPE domain

DOMAIN

  NAME biotechandmoney.com

  CHANGED 2018-01-31

  CREATED 2014-02-07

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

NSERVER

  NS.123-REG.CO.UK 212.67.202.2

  NS2.123-REG.CO.UK 62.138.132.21

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .